Search

Author/Creator Lebowitz, Steven

1. No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer. Issue 5 (May 2023)

Authors:
Liu, Hao; D'Alesio, Mark; AlMasri, Samer; Hammad, Abdulrahman; Desilva, Annissa; Lebowitz, Steven; Rieser, Caroline; Ashwat, Eishan; Hampton, Erica; Khachfe, Hussein; Laffey, Mckenna; Singhi, Aatur; Bahary, Nathan; Lee, Kenneth; Zureikat, Amer; Paniccia, Alessandro
Journal:
HPB
Issue:
Volume 25:Issue 5(2023)
Page Start:
521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients. Issue 3 (March 2023)

Authors:
Liu, Hao; Nassour, Ibrahim; Lebowitz, Steven; D'Alesio, Mark; Hampton, Erica; Desilva, Annissa; Hammad, Abdulrahman; AlMasri, Samer; Khachfe, Hussein H.; Singhi, Aatur; Bahary, Nathan; Lee, Kenneth; Zureikat, Amer; Paniccia, Alessandro
Journal:
HPB
Issue:
Volume 25:Issue 3(2023)
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search